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Abstract 
Although thyroid gland function is mainly under the control of pituitary TSH, other factors, such as iodine, play a role 
in this process. The thyroid is capable of producing different iodolipids such as 6-iodo-deltalactone and 2-
iodohexadecanal (2-IHDA). It was shown that these iodolipids mimic some of the inhibitory effects of excess iodide on 
several thyroid parameters. 
OBJECTIVES:  
To study the effect of 2-IHDA on cell proliferation and apoptosis in FRTL-5 cells. 
RESULTS:  
FRTL-5 cells were grown in the presence of TSH and treated with increasing concentrations of KI and 2-IHDA (0.5, 5, 
10 and 33  µM) for 24, 48 and 72  h. Whereas KI inhibited cell proliferation only at 33  µM after 72  h of treatment, 2-
IHDA inhibited in a time and concentration dependent manner. Analysis of cell cycle by flow cytometric DNA analysis 
revealed an accumulation of cells in G1 phase induced by 2-IHDA. The expression of cyclin A, cyclin D1 and cyclin 
D3 were reduced after treatment with 2-IHDA whereas CDK4 and CDK6 proteins were not modified. 2-IHDA induced 
a dynamic change in cytoplasmic to nuclear accumulation of p21 and p27 causing these proteins to be accumulated 
mostly in the nucleus. We also observed evidence of a pro-apoptotic effect of 2-IHDA at highest concentrations. No 
significant effect of KI was observed. 
CONCLUSION:  
These results suggest that the inhibitory effects of 2-IHDA on FRTL-5 thyroid cell proliferation are mediated by cell 
cycle arrest in G1/S phase and cell death by apoptosis. 
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